A new strategy for the prevention of clostridium difficile infection

Journal of Infectious Diseases

Volumn 207, Issue 10, 2013, Pages 1498-1504

  Howerton, Amber ^a   Patra, Manomita ^a   Abel Santos, Ernesto ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

anti germination; C. difficile; CDI; spore germination

Indexed keywords

BILE SALT; CHOLATE METABENZENE SULFONIC DERIVATIVE; DIMETHYL SULFOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGERMINATION EFFECT; ARTICLE; BACTERIAL SPORE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FECES ANALYSIS; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SINGLE DRUG DOSE; SPORE GERMINATION; SYMPTOM;

ANIMALS; ANTI-BACTERIAL AGENTS; BILE ACIDS AND SALTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLISTIN; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FEMALE; GENTAMICINS; KANAMYCIN; METAGENOME; METRONIDAZOLE; MICE; MICE, INBRED C57BL; SPORES, BACTERIAL; VANCOMYCIN;

EID: 84876544830     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit068     Document Type: Article

References (32)

1. Cohen S, Gerding D, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-55.
2. Kelly CP. Current strategies for management of initial Clostridium difficile infection. J Hosp Med 2012; 7:S5-10.
3. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7:526-36.
4. Kachrimanidou M, Malisiovas N. Clostridium difficile infection: A comprehensive review. Crit Rev Microbiol 2012; 37:178-87.
5. Voelker R. Increased Clostridium difficile virulence demands new treatment approach. J Am Med Assoc 2010; 303:2017-9.
6. Pepin J, Valiquette L, Alary M-E, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004; 171:466-72. (Pubitemid 39179608)
7. Valiquette L, Low DE, Pepin J, McGeer A. Clostridium difficile infection in hospitals: a brewing storm. Can Med Assoc J 2004; 171:27-9. (Pubitemid 38925113)
8. Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 2012; 81:1-14.
9. Burns DA, Minton NP. Sporulation studies in Clostridium difficile. J Microbiol Meth 2011; 87:133-8.
10. Cloud J, Kelly CP. Update on Clostridium difficile associated disease. Curr Opin Gastroenterol 2007; 23:4-9. (Pubitemid 44875902)
11. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2011; 2:145-58.
12. Burns DA, Heap JT, Minton NP. Clostridium difficile spore germination: an update. Res Microbiol 2012; 161:730-4.
13. Moir A. How do spores germinate? J Appl Microbiol 2006; 101:526-30. (Pubitemid 44222283)
14. Paredes-Sabja D, Setlow P, Sarker MR. Germination of spores of Bacillales and Clostridiales species: mechanisms and proteins involved. Trends Microbiol 2011; 19:85-94.
15. Vardakas KZ, Polyzos KA, Patouni K, Rafailidis PI, Samonis G, Falagas ME. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012; 40:1-8.
16. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Can Med Assoc J 2005; 173:1037-42.
17. Cookson B. Hypervirulent strains of Clostridium difficile. Postgrad Med J 2007; 83:291-5. (Pubitemid 46797823)
18. Gerding DN, Muto CA, Owens RC. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008; 46:S43-9. (Pubitemid 351323664)
19. Eyre DW, Walker AS, Griffiths D, et al. Clostridium difficile mixed infection and reinfection. J Clin Microbiol 2012; 50:142-4.
20. McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Rev Gastroenterol Hepatol 2008; 5:40-8.
21. Johnson S. Meeting the challenge of recurrent Clostridium difficile infection. J Hosp Med 2012; 7:S11-3.
22. Kyne L. Clostridium difficile-beyond antibiotics. New Eng J Med 2010; 362:264-5.
23. Kassam Z, Hundal R, Marshall JK, Lee CH. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 2012; 172:191-3.
24. Pant C, Sferra TJ, Deshpande A, Minocha A. Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner. Eur J Internal Med 2011; 22:561-8.
25. Alvarez Z, Abel-Santos E. Potential use of inhibitors of bacteria spore germination in the prophylactic treatment of anthrax and Clostridium difficile-associated disease. Expert Rev Anti Infect Ther 2007; 5:783-92. (Pubitemid 47610942)
26. Jodlowski TZ, Oehler R, Kam LW, Melnychuk I. Emerging therapies in the treatment of Clostridium difficile-associated disease. Ann Pharmacother 2006; 40:2164-9. (Pubitemid 44954435)
27. Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 2008; 190:2505-12. (Pubitemid 351466346)
28. Ramirez N, Liggins M, Abel-Santos E. Kinetic evidence for the presence of putative germination receptors in C. difficile spores. J Bacteriol 2010; 192:4215-22.
29. Howerton A, Ramirez N, Abel-Santos E. Mapping interactions between germinants and Clostridium difficile spores. J Bacteriol 2011; 193:274-82.
30. Hamouda T, Shih AY, Baker JR. A rapid staining technique for the detection of the initiation of germination of bacterial spores. Lett Appl Microbiol 2002; 34:86-90. (Pubitemid 34094022)
31. Sun X, Wang H, Zhang Y, Chen K, Davis B, Feng H. Mouse relapse model of Clostridium difficile infection. Infect Immun 2011; 79:2856-64.
32. Chen X, Katchar K, Goldsmith JD, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterol 2008; 135: 1984-92.